𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of transforming growth factor-β production by interleukin-12

✍ Scribed by Thomas Marth; Warren Strober; Robert A. Seder; Brian L. Kelsall


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
847 KB
Volume
27
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Regulation of transforming growth factor-p production by interleukin-=

The induction of peripheral tolerance following oral antigen administration in several autoimmune disease and conventional animal models correlates with the production of transforming growth factor-fJ (TGF-p) and T helper type 2 (Th2) cytokines. The factors regulating TGF-P production and its relation to the Th2 response, however, have not been defined. We demonstrate that the systemic administration of antibodies to interleukin (1L)-12 to ovalbumin (0VA)-T cell receptor (TCR) transgenic mice fed high doses of OVA, followed by systemic OVA challenge, substantially enhances TGF-P, but not IL-4 production by peripheral T cells. Furthermore, we demonstrate in an in vitro T cell differentiation model that naive (CD4+/Mel-14hi) OVA-TCR-T cells stimulated with OVApulsed dendritic cells (DC) produce four-to fivefold higher amounts of TGF-P when cultured with anti-IL-12 or anti-interferon-y (IFN-y). In this in vitro system, IL-4 was not required for TGF-P production by T cells; however, it appeared to enhance levels of TGF-P by promoting the growth of TGF-pproducing cells. Our findings demonstrate that IL-12 and IFN-y are important negative regulators of TGF-P production both in vivo and in vitro, and that their modulation may be of benefit for the treatment of autoimmune disorders.

In recent studies TGF-P has been shown to play a role in oral tolerance. Thus, as reviewed by Weiner et al. [12], repeated antigen feeding (particularly at low doses) is associated with the appearance of antigen-specific T cells [I 163931


📜 SIMILAR VOLUMES


Transforming growth factor β regulation
✍ Harold L. Moses; Robert J. Coffey Jr.; Edward B. Leof; Russette M. Lyons; Jorma 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

JORMA KESKI-OJA Two types of transforming growth factors (TGF) have been purified and well characterized, TGFa and TGFP. TGFa is a 5.6 kD single chain molecule that shows sequence homology to epidermal growth factor (EGF), binds to the EGF receptor, and has biological effects very similar to those o

Transforming growth factor type β regula
✍ Edward B. Leof; Jacqueline A. Proper; Michael J. Getz; Harold L. Moses 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Stimulation of quiescent cultures of AKR-2B cells with transforming growth factor type P (TGFP) resulted in a transitory increase in actin cytoplasmic poly(A) + RNA. Levels of actin rnRNA peaked approximately 4-8 hours subsequent to TGFP addition and approached basal levels by 24 hours. The accumula

Transforming growth factor-β up-regulate
✍ Yayoi Tada; Akihiko Asahina; Koichiro Nakamura; Kohei Miyazono; Michio Tomura; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Transforming growth factor (TGF)-g is an immunosuppressive agent that is efficacious in suppressing a wide variety of cell-mediated immune responses. However, the direct effect of this cytokine on Langerhans cells (LC) has not been clarified. In this study, we examined its modulatory effects on the